Lipocine Inc.
Lipocine Inc. (LPCN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LPCN · as of Jun 9, 2026
Key Statistics
Explore Lipocine Inc. Data
lpcn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The LPCN analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $10.50, representing +414.71% upside from the current price of $2.04.
Competitors & Peers
lpcn competitorsLPCN
ADAP
ANL
BLRX
EDSA
ERNAStock Performance
Full HistoryAbout Lipocine Inc.
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic condi…
what is lipocine inc. · lpcn stock overview · lipocine inc. company profile · who is lipocine inc. ceo · lpcn NASDAQ · lipocine inc. headquarters · lipocine inc. business segments
About Stock Overview & Key Data
Lipocine Inc. (LPCN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 22, 2013. As of the latest trading session, LPCN stock price is $2.04, with a market capitalization of $11.8M. The stock has returned -39.47% over the past 12 months and -74.60% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Lipocine Inc. stock is Buy, with an average 12-month price target of $10.50. In fiscal year 2025, Lipocine Inc. reported revenue of $2.0M and net income of -$9.6M. For detailed data — including Lipocine Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lipocine Inc. (LPCN) stock price is $2.04. The stock is traded on NASDAQ under the ticker symbol LPCN. The 52-week range is $1.81 – $12.37.